| Heather Dunn Antoine, DO | |
|
1919 E Thomas Rd, Phoenix, AZ 85016-7710 | |
| (602) 933-0777 | |
| (602) 933-0755 |
| Full Name | Heather Dunn Antoine |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 1919 E Thomas Rd, Phoenix, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598056533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 35281 (Arizona) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Entity Name | Phoenix Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922112044 PECOS PAC ID: 0446278584 Enrollment ID: O20051107000704 |
News Archive
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
LTC Properties, Inc. announces today operating results for the quarter ended December 31, 2013. The Company reported an increase of 13.8% in Funds from Operations ("FFO") to $20.0 million in the quarter ended December 31, 2013, from $17.5 million in the comparable 2012 period.
In some states, the task of helping consumers find their way through the health law's new online insurance marketplace has fallen to "navigators." In general, though, news outlets report on the strategies and public outreach efforts underway in locations across the country.
Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studies in patients with chronic hepatitis C virus (HCV) genotype 1 infection, the addition of boceprevir to treatment with PEGINTRON® and REBETOL® significantly increased the number of patients who achieved sustained virologic response, compared to control groups that received Peg/riba plus placebo.
A new discovery about the malaria-related parasite Toxoplasma gondii - which can threaten babies, AIDS patients, the elderly and others with weakened immune function - may help solve the mystery of how this single-celled parasite establishes life-long infections in people.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Dunn Antoine, DO 1919 E Thomas Rd, Phoenix, AZ 85016-7710 Ph: (602) 933-0777 | Heather Dunn Antoine, DO 1919 E Thomas Rd, Phoenix, AZ 85016-7710 Ph: (602) 933-0777 |
News Archive
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
LTC Properties, Inc. announces today operating results for the quarter ended December 31, 2013. The Company reported an increase of 13.8% in Funds from Operations ("FFO") to $20.0 million in the quarter ended December 31, 2013, from $17.5 million in the comparable 2012 period.
In some states, the task of helping consumers find their way through the health law's new online insurance marketplace has fallen to "navigators." In general, though, news outlets report on the strategies and public outreach efforts underway in locations across the country.
Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studies in patients with chronic hepatitis C virus (HCV) genotype 1 infection, the addition of boceprevir to treatment with PEGINTRON® and REBETOL® significantly increased the number of patients who achieved sustained virologic response, compared to control groups that received Peg/riba plus placebo.
A new discovery about the malaria-related parasite Toxoplasma gondii - which can threaten babies, AIDS patients, the elderly and others with weakened immune function - may help solve the mystery of how this single-celled parasite establishes life-long infections in people.
› Verified 5 days ago
Dr. Timur Raghib, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-0777 | |
Dr. Kenneth Veiga, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1930 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-532-1000 | |
Patrick S Sciara, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 19829 N 27th Ave, Phoenix, AZ 85027 Phone: 623-879-1866 Fax: 623-879-1876 | |
Lindley T Bliss, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 350 W Thomas Rd, Phoenix, AZ 85013 Phone: 602-615-5672 Fax: 902-978-0158 | |
Dr. Nina Souders, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-0777 | |
Reina Manilal Patel, D.O. Hospitalist Medicare: Medicare Enrolled Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-0777 Fax: 602-933-0755 | |
Homan Salehi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9201 W Thomas Rd, Phoenix, AZ 85037 Phone: 623-327-7313 Fax: 623-327-5437 |